LJUBLJANA (Slovenia), June 27 (SeeNews) - Slovenian pharmaceutical products wholesaler Salus [LJE:SALR] has submitted a binding bid for the purchase of a 75% stake in the capital of local sector player Farmadent, Salus said.
The bid includes an option for the purchase of the remaining 25% stake in Farmadent, or alternatively the company's entire capital, Salus said in a filing with the Ljubljana Stock Exchange on Friday.
You can subscribe to our M&A newsletter here
The offer was submitted on the basis of an invitation for public bidding published by Maribor municipality in Slovenia's Official Gazette in February 2022, Salus said.
The potential acquisition of Farmadent is in line with the Salus' development strategy, which envisages the expansion of activities in regions where it is not yet present.
Ljubljana-based Salus is one of Slovenia's leading wholesalers of pharmaceutical and medical products.